The global Diagnostic Nuclear Medicines market is projected to grow from US$ 5049 million in 2024 to US$ 7534.8 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period.

Diagnostic Nuclear Medicines Market

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.

Report Covers:

This report presents an overview of global market for Diagnostic Nuclear Medicines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Diagnostic Nuclear Medicines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Diagnostic Nuclear Medicines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diagnostic Nuclear Medicines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Diagnostic Nuclear Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Diagnostic Nuclear Medicines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Diagnostic Nuclear Medicines Market Report

Report Metric	Details
Report Name	Diagnostic Nuclear Medicines Market
Accounted market size in 2024	US$ 5049 in million
Forecasted market size in 2030	US$ 7534.8 million
CAGR	6.9
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Tc-99m F-18 Other
Segment by Application	Oncology Cardiology Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Diagnostic Nuclear Medicines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Diagnostic Nuclear Medicines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diagnostic Nuclear Medicines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Nuclear Medicines Market growing?

Ans: The Diagnostic Nuclear Medicines Market witnessing a CAGR of 6.9 during the forecast period 2025-2030.

What is the Diagnostic Nuclear Medicines Market size in 2030?

Ans: The Diagnostic Nuclear Medicines Market size in 2030 will be US$ 7534.8 million.

Who are the main players in the Diagnostic Nuclear Medicines Market report?

Ans: The main players in the Diagnostic Nuclear Medicines Market are Curium Pharma, Jubilant Pharma, Bracco Imaging, Novartis, SIEMENS, China Isotope & Radiation, Dongcheng, Lantheus, Eli Lilly

What are the Application segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Applications covered in the Diagnostic Nuclear Medicines Market report are Oncology, Cardiology, Other

What are the Type segmentation covered in the Diagnostic Nuclear Medicines Market report?

Ans: The Types covered in the Diagnostic Nuclear Medicines Market report are Tc-99m, F-18, Other

1 Study Coverage

1.1 Diagnostic Nuclear Medicines Product Introduction

1.2 Market by Type

1.2.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Tc-99m

1.2.3 F-18

1.2.4 Other

1.3 Market by Application

1.3.1 Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts 2019-2030

2.2 Global Diagnostic Nuclear Medicines Revenue by Region

2.2.1 Global Diagnostic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Diagnostic Nuclear Medicines Revenue by Region (2019-2024)

2.2.3 Global Diagnostic Nuclear Medicines Revenue by Region (2025-2030)

2.2.4 Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2030)

2.3 Global Diagnostic Nuclear Medicines Sales Estimates and Forecasts 2019-2030

2.4 Global Diagnostic Nuclear Medicines Sales by Region

2.4.1 Global Diagnostic Nuclear Medicines Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Diagnostic Nuclear Medicines Sales by Region (2019-2024)

2.4.3 Global Diagnostic Nuclear Medicines Sales by Region (2025-2030)

2.4.4 Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Diagnostic Nuclear Medicines Sales by Manufacturers

3.1.1 Global Diagnostic Nuclear Medicines Sales by Manufacturers (2019-2024)

3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Diagnostic Nuclear Medicines in 2023

3.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturers

3.2.1 Global Diagnostic Nuclear Medicines Revenue by Manufacturers (2019-2024)

3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Medicines Revenue in 2023

3.3 Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Diagnostic Nuclear Medicines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Offered and Application

3.8 Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Diagnostic Nuclear Medicines Sales by Type

4.1.1 Global Diagnostic Nuclear Medicines Historical Sales by Type (2019-2024)

4.1.2 Global Diagnostic Nuclear Medicines Forecasted Sales by Type (2025-2030)

4.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

4.2 Global Diagnostic Nuclear Medicines Revenue by Type

4.2.1 Global Diagnostic Nuclear Medicines Historical Revenue by Type (2019-2024)

4.2.2 Global Diagnostic Nuclear Medicines Forecasted Revenue by Type (2025-2030)

4.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

4.3 Global Diagnostic Nuclear Medicines Price by Type

4.3.1 Global Diagnostic Nuclear Medicines Price by Type (2019-2024)

4.3.2 Global Diagnostic Nuclear Medicines Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Diagnostic Nuclear Medicines Sales by Application

5.1.1 Global Diagnostic Nuclear Medicines Historical Sales by Application (2019-2024)

5.1.2 Global Diagnostic Nuclear Medicines Forecasted Sales by Application (2025-2030)

5.1.3 Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

5.2 Global Diagnostic Nuclear Medicines Revenue by Application

5.2.1 Global Diagnostic Nuclear Medicines Historical Revenue by Application (2019-2024)

5.2.2 Global Diagnostic Nuclear Medicines Forecasted Revenue by Application (2025-2030)

5.2.3 Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

5.3 Global Diagnostic Nuclear Medicines Price by Application

5.3.1 Global Diagnostic Nuclear Medicines Price by Application (2019-2024)

5.3.2 Global Diagnostic Nuclear Medicines Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Diagnostic Nuclear Medicines Market Size by Type

6.1.1 US & Canada Diagnostic Nuclear Medicines Sales by Type (2019-2030)

6.1.2 US & Canada Diagnostic Nuclear Medicines Revenue by Type (2019-2030)

6.2 US & Canada Diagnostic Nuclear Medicines Market Size by Application

6.2.1 US & Canada Diagnostic Nuclear Medicines Sales by Application (2019-2030)

6.2.2 US & Canada Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

6.3 US & Canada Diagnostic Nuclear Medicines Market Size by Country

6.3.1 US & Canada Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Diagnostic Nuclear Medicines Sales by Country (2019-2030)

6.3.3 US & Canada Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Diagnostic Nuclear Medicines Market Size by Type

7.1.1 Europe Diagnostic Nuclear Medicines Sales by Type (2019-2030)

7.1.2 Europe Diagnostic Nuclear Medicines Revenue by Type (2019-2030)

7.2 Europe Diagnostic Nuclear Medicines Market Size by Application

7.2.1 Europe Diagnostic Nuclear Medicines Sales by Application (2019-2030)

7.2.2 Europe Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

7.3 Europe Diagnostic Nuclear Medicines Market Size by Country

7.3.1 Europe Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Diagnostic Nuclear Medicines Sales by Country (2019-2030)

7.3.3 Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Diagnostic Nuclear Medicines Market Size

8.1.1 China Diagnostic Nuclear Medicines Sales (2019-2030)

8.1.2 China Diagnostic Nuclear Medicines Revenue (2019-2030)

8.2 China Diagnostic Nuclear Medicines Market Size by Application

8.2.1 China Diagnostic Nuclear Medicines Sales by Application (2019-2030)

8.2.2 China Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Diagnostic Nuclear Medicines Market Size by Type

9.1.1 Asia Diagnostic Nuclear Medicines Sales by Type (2019-2030)

9.1.2 Asia Diagnostic Nuclear Medicines Revenue by Type (2019-2030)

9.2 Asia Diagnostic Nuclear Medicines Market Size by Application

9.2.1 Asia Diagnostic Nuclear Medicines Sales by Application (2019-2030)

9.2.2 Asia Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

9.3 Asia Diagnostic Nuclear Medicines Sales by Region

9.3.1 Asia Diagnostic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Diagnostic Nuclear Medicines Revenue by Region (2019-2030)

9.3.3 Asia Diagnostic Nuclear Medicines Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Market Size by Type

10.1.1 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Market Size by Application

10.2.1 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country

10.3.1 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Information

11.1.2 Cardinal Health Overview

11.1.3 Cardinal Health Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Cardinal Health Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Cardinal Health Recent Developments

11.2 GE Healthcare

11.2.1 GE Healthcare Company Information

11.2.2 GE Healthcare Overview

11.2.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 GE Healthcare Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GE Healthcare Recent Developments

11.3 Curium Pharma

11.3.1 Curium Pharma Company Information

11.3.2 Curium Pharma Overview

11.3.3 Curium Pharma Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Curium Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Curium Pharma Recent Developments

11.4 Jubilant Pharma

11.4.1 Jubilant Pharma Company Information

11.4.2 Jubilant Pharma Overview

11.4.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Jubilant Pharma Recent Developments

11.5 Bracco Imaging

11.5.1 Bracco Imaging Company Information

11.5.2 Bracco Imaging Overview

11.5.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Bracco Imaging Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Bracco Imaging Recent Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis Overview

11.6.3 Novartis Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Novartis Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Novartis Recent Developments

11.7 SIEMENS

11.7.1 SIEMENS Company Information

11.7.2 SIEMENS Overview

11.7.3 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 SIEMENS Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 SIEMENS Recent Developments

11.8 China Isotope & Radiation

11.8.1 China Isotope & Radiation Company Information

11.8.2 China Isotope & Radiation Overview

11.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 China Isotope & Radiation Recent Developments

11.9 Dongcheng

11.9.1 Dongcheng Company Information

11.9.2 Dongcheng Overview

11.9.3 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Dongcheng Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Dongcheng Recent Developments

11.10 Lantheus

11.10.1 Lantheus Company Information

11.10.2 Lantheus Overview

11.10.3 Lantheus Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Lantheus Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Lantheus Recent Developments

11.11 Eli Lilly

11.11.1 Eli Lilly Company Information

11.11.2 Eli Lilly Overview

11.11.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Eli Lilly Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Eli Lilly Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Diagnostic Nuclear Medicines Industry Chain Analysis

12.2 Diagnostic Nuclear Medicines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Diagnostic Nuclear Medicines Production Mode & Process

12.4 Diagnostic Nuclear Medicines Sales and Marketing

12.4.1 Diagnostic Nuclear Medicines Sales Channels

12.4.2 Diagnostic Nuclear Medicines Distributors

12.5 Diagnostic Nuclear Medicines Customers

13 Market Dynamics

13.1 Diagnostic Nuclear Medicines Industry Trends

13.2 Diagnostic Nuclear Medicines Market Drivers

13.3 Diagnostic Nuclear Medicines Market Challenges

13.4 Diagnostic Nuclear Medicines Market Restraints

14 Key Findings in The Global Diagnostic Nuclear Medicines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Bracco Imaging

Lantheus

GE Healthcare

China Isotope & Radiation

List of Tables

Table 1. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Tc-99m

Table 3. Major Manufacturers of F-18

Table 4. Major Manufacturers of Other

Table 5. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2024)

Table 10. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2025-2030)

Table 11. Global Diagnostic Nuclear Medicines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 13. Global Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 14. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2024)

Table 15. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2025-2030)

Table 16. Global Diagnostic Nuclear Medicines Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Diagnostic Nuclear Medicines Sales Share by Manufacturers (2019-2024)

Table 18. Global Diagnostic Nuclear Medicines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Diagnostic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Diagnostic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Diagnostic Nuclear Medicines Price by Manufacturers 2019-2024 (USD/Unit)

Table 22. Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Diagnostic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Medicines as of 2023)

Table 24. Global Key Manufacturers of Diagnostic Nuclear Medicines, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Diagnostic Nuclear Medicines, Product Offered and Application

Table 26. Global Key Manufacturers of Diagnostic Nuclear Medicines, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 29. Global Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 30. Global Diagnostic Nuclear Medicines Sales Share by Type (2019-2024)

Table 31. Global Diagnostic Nuclear Medicines Sales Share by Type (2025-2030)

Table 32. Global Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Diagnostic Nuclear Medicines Revenue Share by Type (2019-2024)

Table 35. Global Diagnostic Nuclear Medicines Revenue Share by Type (2025-2030)

Table 36. Diagnostic Nuclear Medicines Price by Type (2019-2024) & (USD/Unit)

Table 37. Global Diagnostic Nuclear Medicines Price Forecast by Type (2025-2030) & (USD/Unit)

Table 38. Global Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 39. Global Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 40. Global Diagnostic Nuclear Medicines Sales Share by Application (2019-2024)

Table 41. Global Diagnostic Nuclear Medicines Sales Share by Application (2025-2030)

Table 42. Global Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Diagnostic Nuclear Medicines Revenue Share by Application (2019-2024)

Table 45. Global Diagnostic Nuclear Medicines Revenue Share by Application (2025-2030)

Table 46. Diagnostic Nuclear Medicines Price by Application (2019-2024) & (USD/Unit)

Table 47. Global Diagnostic Nuclear Medicines Price Forecast by Application (2025-2030) & (USD/Unit)

Table 48. US & Canada Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 61. Europe Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 62. Europe Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 63. Europe Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 66. Europe Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 67. Europe Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 73. Europe Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 74. China Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 75. China Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 76. China Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 79. China Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 80. China Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 83. Asia Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 84. Asia Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 87. Asia Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 88. Asia Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Diagnostic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Diagnostic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Diagnostic Nuclear Medicines Sales by Region (2019-2024) & (K Units)

Table 94. Asia Diagnostic Nuclear Medicines Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales by Country (2025-2030) & (K Units)

Table 108. Cardinal Health Company Information

Table 109. Cardinal Health Description and Major Businesses

Table 110. Cardinal Health Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 111. Cardinal Health Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Cardinal Health Recent Developments

Table 113. GE Healthcare Company Information

Table 114. GE Healthcare Description and Major Businesses

Table 115. GE Healthcare Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 116. GE Healthcare Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. GE Healthcare Recent Developments

Table 118. Curium Pharma Company Information

Table 119. Curium Pharma Description and Major Businesses

Table 120. Curium Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 121. Curium Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Curium Pharma Recent Developments

Table 123. Jubilant Pharma Company Information

Table 124. Jubilant Pharma Description and Major Businesses

Table 125. Jubilant Pharma Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 126. Jubilant Pharma Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Jubilant Pharma Recent Developments

Table 128. Bracco Imaging Company Information

Table 129. Bracco Imaging Description and Major Businesses

Table 130. Bracco Imaging Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 131. Bracco Imaging Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Bracco Imaging Recent Developments

Table 133. Novartis Company Information

Table 134. Novartis Description and Major Businesses

Table 135. Novartis Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 136. Novartis Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Novartis Recent Developments

Table 138. SIEMENS Company Information

Table 139. SIEMENS Description and Major Businesses

Table 140. SIEMENS Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 141. SIEMENS Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. SIEMENS Recent Developments

Table 143. China Isotope & Radiation Company Information

Table 144. China Isotope & Radiation Description and Major Businesses

Table 145. China Isotope & Radiation Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 146. China Isotope & Radiation Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. China Isotope & Radiation Recent Developments

Table 148. Dongcheng Company Information

Table 149. Dongcheng Description and Major Businesses

Table 150. Dongcheng Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 151. Dongcheng Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Dongcheng Recent Developments

Table 153. Lantheus Company Information

Table 154. Lantheus Description and Major Businesses

Table 155. Lantheus Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 156. Lantheus Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Lantheus Recent Developments

Table 158. Eli Lilly Company Information

Table 159. Eli Lilly Description and Major Businesses

Table 160. Eli Lilly Diagnostic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 161. Eli Lilly Diagnostic Nuclear Medicines Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Eli Lilly Recent Developments

Table 163. Key Raw Materials Lists

Table 164. Raw Materials Key Suppliers Lists

Table 165. Diagnostic Nuclear Medicines Distributors List

Table 166. Diagnostic Nuclear Medicines Customers List

Table 167. Diagnostic Nuclear Medicines Market Trends

Table 168. Diagnostic Nuclear Medicines Market Drivers

Table 169. Diagnostic Nuclear Medicines Market Challenges

Table 170. Diagnostic Nuclear Medicines Market Restraints

Table 171. Research Programs/Design for This Report

Table 172. Key Data Information from Secondary Sources

Table 173. Key Data Information from Primary Sources

List of Figures

Figure 1. Diagnostic Nuclear Medicines Product Picture

Figure 2. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Diagnostic Nuclear Medicines Market Share by Type in 2023 & 2030

Figure 4. Tc-99m Product Picture

Figure 5. F-18 Product Picture

Figure 6. Other Product Picture

Figure 7. Global Diagnostic Nuclear Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Diagnostic Nuclear Medicines Market Share by Application in 2023 & 2030

Figure 9. Oncology

Figure 10. Cardiology

Figure 11. Other

Figure 12. Diagnostic Nuclear Medicines Report Years Considered

Figure 13. Global Diagnostic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Diagnostic Nuclear Medicines Revenue 2019-2030 (US$ Million)

Figure 15. Global Diagnostic Nuclear Medicines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Diagnostic Nuclear Medicines Revenue Market Share by Region (2019-2030)

Figure 17. Global Diagnostic Nuclear Medicines Sales 2019-2030 ((K Units)

Figure 18. Global Diagnostic Nuclear Medicines Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 22. Europe Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 24. China Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Diagnostic Nuclear Medicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Diagnostic Nuclear Medicines in the World: Market Share by Diagnostic Nuclear Medicines Revenue in 2023

Figure 31. Global Diagnostic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 33. Global Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 34. Global Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 35. Global Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 41. US & Canada Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 42. U.S. Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 45. Europe Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 46. Europe Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 47. Europe Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 48. Europe Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 49. Europe Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 50. Germany Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 51. France Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 55. China Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 56. China Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 57. China Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 58. China Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 59. Asia Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 60. Asia Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 61. Asia Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 62. Asia Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 63. Asia Diagnostic Nuclear Medicines Revenue Share by Region (2019-2030)

Figure 64. Asia Diagnostic Nuclear Medicines Sales Share by Region (2019-2030)

Figure 65. Japan Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 69. India Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Diagnostic Nuclear Medicines Sales Share by Country (2019-2030)

Figure 76. Brazil Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Diagnostic Nuclear Medicines Revenue (2019-2030) & (US$ Million)

Figure 81. Diagnostic Nuclear Medicines Value Chain

Figure 82. Diagnostic Nuclear Medicines Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Infantile Spasm Relief Medication Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12K19035

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Corticosteroid API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-21K14628

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Pre-filled Normal Saline Syringe Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32H18872

Fri Feb 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Multidose Dropper System for Ophthalmic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3J10777

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions